Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
Affecting one out of every six men, prostate cancer is the second most common type of cancer in American men. It can begin as a tumor in the prostate gland and spread.
About half of the risk of prostate cancer can be attributed to genetic factors. There is no single gene that puts you at risk; rather, there appears to be multiple inherited genetic variants that contribute slightly to risk. These, combined with environmental
factors, lead to prostate cancer.
Other factors that increase your risk for developing prostate cancer are:
Ages 18-40: Usually not required.
Ages 40-49: You should discuss your risk level with your physician. Screening is recommended if you are considered high risk, including if you are African-American or have a family history of prostate cancer. This includes prostate-specific
antigen (PSA) screening, a test that measures the blood level of PSA, a protein that is produced by the prostate gland.
Ages 50+: You should discuss screening with your physician.
Observation is safe, cost-saving in low-risk prostate cancer
Progress and promise in prostate cancer research
Some men voice complaints of shortened penis following prostate cancer treatment
Researchers find culprit in castration-resistant prostate cancer
New Patient Appointments
For adults: 877-442-3324For children: 888-733-4662